| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cns Pharmaceuticals, Inc. (CNSP) has 8 insiders with recent SEC Form 4 filings, including 3 buys and 17 sells. CNSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 19.0K | $104.9K | - | |
| CEO | 9.8K | $53.9K | - | |
| CFO | 4.9K | $26.9K | - | |
| ? | 1.5K | $8.4K | - | |
| ? | 1.5K | $8.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2023 | Priebe Waldemar74 | - | Sell | 94,298 | $1.41 | $133,114.14 | -2.6% | +115.2% | -62.6% | |
| Dec 6, 2021 | Downs Christopher | Chief Financial Officer | Buy | 5,000 | $0.94 | $4,701.50 | +3.4% | -71.7% | -91.1% | |
| Nov 19, 2021 | Downs Christopher | Chief Financial Officer | Buy | 4,500 | $1.15 | $5,191.65 | +3.2% | -70.9% | -82.5% | |
| Aug 24, 2020 | Downs Christopher | Chief Financial Officer | Buy | 142,000 | $2.04 | $289,680.00 | New | - | - |